title: Neurobiological mechanisms that contribute to stress-related cocaine use.
abstract: The ability of stressful life events to trigger drug use is particularly problematic for the management of cocaine addiction due to the unpredictable and often uncontrollable nature of stress. For this reason, understanding the neurobiological processes that contribute to stress-related drug use is important for the development of new and more effective treatment strategies aimed at minimizing the role of stress in the addiction cycle. In this review we discuss the neurocircuitry that has been implicated in stress-induced drug use with an emphasis on corticotropin releasing factor actions in the ventral tegmental area (VTA) and an important pathway from the bed nucleus of the stria terminalis to the VTA that is regulated by norepinephrine via actions at beta adrenergic receptors. In addition to the neurobiological mechanisms that underlie stress-induced cocaine seeking, we review findings suggesting that the ability of stressful stimuli to trigger cocaine use emerges and intensifies in an intake-dependent manner with repeated cocaine self-administration. Further, we discuss evidence that the drug-induced neuroadaptations that are necessary for heightened susceptibility to stress-induced drug use are reliant on elevated levels of glucocorticoid hormones at the time of cocaine use. Finally, the potential ability of stress to function as a "stage setter" for drug use - increasing sensitivity to cocaine and drug-associated cues - under conditions where it does not directly trigger cocaine seeking is discussed. As our understanding of the mechanisms through which stress promotes drug use advances, the hope is that so too will the available tools for effectively managing addiction, particularly in cocaine addicts whose drug use is stress-driven. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
authors.affiliation: Department of Biomedical Sciences, Box 1881, Marquette University, Milwaukee, WI 53201, USA. Electronic address: john.mantsch@marquette.edu.
authors.forename: John R
authors.initials: JR
authors.lastname: Mantsch
authors.forename: Oliver
authors.initials: O
authors.lastname: Vranjkovic
authors.forename: Robert C
authors.initials: RC
authors.lastname: Twining
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Gasser
authors.forename: Jayme R
authors.initials: JR
authors.lastname: McReynolds
authors.forename: Jordan M
authors.initials: JM
authors.lastname: Blacktop
mesh_terms: D000818:Animals; D019970:Cocaine-Related Disorders / Q000150:complications / Q000378:metabolism / Q000473:pathology; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D005938:Glucocorticoids / Q000378:metabolism; D006801:Humans; D009446:Neurobiology; D009638:Norepinephrine / Q000378:metabolism; D012201:Reward; D013315:Stress, Psychological / Q000150:complications*; D017557:Ventral Tegmental Area
chemical_list: D005938:Glucocorticoids; D003346:Corticotropin-Releasing Hormone; D009638:Norepinephrine
keywords: CRF; Cocaine; Glucocorticoid; Norepinephrine; Relapse; Review; Stress
references.citation: Mol Pharmacol. 2005 May;67(5):1612-9
references.pmid: 15662045
references.citation: Brain Res. 1990 Oct 29;531(1-2):322-8
references.pmid: 1963104
references.citation: Brain Res. 2010 Feb 16;1314:38-43
references.pmid: 19800323
references.citation: J Neurosci. 2012 Dec 12;32(50):18035-46
references.pmid: 23238719
references.citation: Exp Neurol. 2013 Jan;239:120-32
references.pmid: 23063907
references.citation: Eur J Pharmacol. 2008 May 13;585(2-3):473-82
references.pmid: 18417120
references.citation: J Neurophysiol. 2001 Dec;86(6):2911-8
references.pmid: 11731547
references.citation: J Neurochem. 2008 Aug;106(3):1471-82
references.pmid: 18513366
references.citation: Behav Pharmacol. 1999 Sep;10(5):523-9
references.pmid: 10780258
references.citation: Psychopharmacology (Berl). 2003 Jul;168(1-2):170-176
references.pmid: 12845419
references.citation: Psychopharmacology (Berl). 2005 Dec;183(2):171-80
references.pmid: 16163517
references.citation: Nat Neurosci. 2009 Mar;12(3):247-9
references.pmid: 19234455
references.citation: Mol Psychiatry. 1996 Sep;1(4):265-77
references.pmid: 9118350
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):301-6
references.pmid: 11134516
references.citation: Psychopharmacology (Berl). 2006 May;185(4):459-70
references.pmid: 16555060
references.citation: Neuropharmacology. 2006 Jun;50(8):941-52
references.pmid: 16581093
references.citation: Psychoneuroendocrinology. 2003 Oct;28(7):836-62
references.pmid: 12892653
references.citation: J Comp Neurol. 2008 Feb 1;506(4):616-26
references.pmid: 18067140
references.citation: Eur J Neurosci. 2000 Jan;12(1):292-302
references.pmid: 10651884
references.citation: Psychopharmacology (Berl). 1997 Aug;132(3):289-95
references.pmid: 9292629
references.citation: Psychopharmacology (Berl). 2006 Jul;187(1):60-7
references.pmid: 16598453
references.citation: Neuroscience. 2003;119(2):497-505
references.pmid: 12770563
references.citation: Psychopharmacology (Berl). 2003 Jul;168(1-2):66-74
references.pmid: 12442201
references.citation: Am J Addict. 2007 May-Jun;16(3):174-82
references.pmid: 17612820
references.citation: Drug Alcohol Depend. 2002 Jan 1;65(2):115-27
references.pmid: 11772473
references.citation: Eur J Pharmacol. 2000 Jan 3;387(1):59-62
references.pmid: 10633161
references.citation: J Neurosci. 2008 Dec 17;28(51):13856-65
references.pmid: 19091975
references.citation: J Comp Neurol. 2008 Jul 20;509(3):302-18
references.pmid: 18478589
references.citation: J Neurosci. 1998 Oct 1;18(19):8003-15
references.pmid: 9742167
references.citation: J Neurobiol. 2001 Nov 15;49(3):245-53
references.pmid: 11745662
references.citation: J Neurosci. 1999 Oct 15;19(20):RC35
references.pmid: 10516337
references.citation: Neuron. 2003 Feb 20;37(4):577-82
references.pmid: 12597856
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4894-9
references.pmid: 19261850
references.citation: Nat Med. 2001 Oct;7(10):1151-4
references.pmid: 11590440
references.citation: Psychopharmacology (Berl). 2009 Sep;205(4):565-75
references.pmid: 19484223
references.citation: Eur J Pharmacol. 2008 Apr 7;583(2-3):174-85
references.pmid: 18282566
references.citation: J Neurosci. 2003 Jun 1;23(11):4785-90
references.pmid: 12805318
references.citation: J Comp Neurol. 2009 Feb 1;512(4):529-55
references.pmid: 19025979
references.citation: Psychopharmacology (Berl). 1996 Dec;128(4):408-12
references.pmid: 8986011
references.citation: Brain Res Rev. 2008 Jun;58(1):1-17
references.pmid: 18199483
references.citation: Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18459-64
references.pmid: 22032926
references.citation: J Chem Neuroanat. 1997 Jul;13(2):115-39
references.pmid: 9285356
references.citation: Psychopharmacology (Berl). 2008 Jan;195(4):591-603
references.pmid: 17899015
references.citation: Neuron. 2008 Feb 28;57(4):559-70
references.pmid: 18304485
references.citation: Psychopharmacology (Berl). 2009 Mar;203(1):121-30
references.pmid: 18985323
references.citation: Science. 1998 Oct 9;282(5387):298-300
references.pmid: 9765157
references.citation: Neurochem Res. 1991 Dec;16(12):1253-6
references.pmid: 1664493
references.citation: J Pharmacol Exp Ther. 2012 Aug;342(2):541-51
references.pmid: 22593095
references.citation: Psychopharmacology (Berl). 2007 Aug;193(2):283-94
references.pmid: 17437087
references.citation: Neuroscience. 2009 Sep 29;163(1):339-51
references.pmid: 19527774
references.citation: Eur J Pharmacol. 2001 Dec 7;432(2-3):153-61
references.pmid: 11740951
references.citation: J Pharmacol Exp Ther. 1999 Jun;289(3):1641-7
references.pmid: 10336563
references.citation: J Physiol. 2008 Apr 15;586(8):2157-70
references.pmid: 18308824
references.citation: Neuropsychopharmacology. 2004 Apr;29(4):686-93
references.pmid: 14872205
references.citation: Neuropsychopharmacology. 2007 Feb;32(2):367-76
references.pmid: 16641943
references.citation: J Neurosci. 2009 Apr 15;29(15):4846-57
references.pmid: 19369553
references.citation: J Chem Neuroanat. 1990 Sep-Oct;3(5):355-66
references.pmid: 1977414
references.citation: Brain Res. 2003 Nov 14;990(1-2):209-14
references.pmid: 14568346
references.citation: Psychopharmacology (Berl). 2008 Sep;200(1):59-70
references.pmid: 18575850
references.citation: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references.pmid: 19710631
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11851-6
references.pmid: 15280545
references.citation: J Neurosci. 2006 Aug 23;26(34):8758-66
references.pmid: 16928864
references.citation: Proc Natl Acad Sci U S A. 1986 Dec;83(24):9779-83
references.pmid: 2879285
references.citation: Neuropsychopharmacology. 2011 Jun;36(7):1444-54
references.pmid: 21412222
references.citation: Psychopharmacology (Berl). 2009 Jul;204(4):693-703
references.pmid: 19266184
references.citation: Nature. 2013 Apr 11;496(7444):224-8
references.pmid: 23515155
references.citation: Psychopharmacology (Berl). 2000 Jun;150(3):317-24
references.pmid: 10923760
references.citation: J Neurosci. 2004 Sep 22;24(38):8198-204
references.pmid: 15385602
references.citation: Cereb Cortex. 2000 Dec;10(12):1168-75
references.pmid: 11073866
references.citation: J Pharmacol Exp Ther. 2005 Jul;314(1):201-6
references.pmid: 15784652
references.citation: Psychopharmacology (Berl). 2011 Nov;218(1):83-8
references.pmid: 21399902
references.citation: Psychopharmacology (Berl). 1999 Mar;142(4):343-51
references.pmid: 10229058
references.citation: Nat Neurosci. 2008 Dec;11(12):1376-7
references.pmid: 18978779
references.citation: J Biol Chem. 2004 Nov 26;279(48):50042-9
references.pmid: 15448143
references.citation: Neuropsychopharmacology. 2010 Oct;35(11):2165-78
references.pmid: 20613718
references.citation: Behav Brain Res. 2011 Mar 1;217(2):472-6
references.pmid: 20933023
references.citation: J Neurosci. 2005 Jun 1;25(22):5389-96
references.pmid: 15930388
references.citation: Biol Psychiatry. 2010 Aug 1;68(3):303-5
references.pmid: 20494337
references.citation: Psychopharmacology (Berl). 2001 Dec;158(4):360-5
references.pmid: 11797056
references.citation: Science. 2011 Sep 30;333(6051):1903-7
references.pmid: 21885734
references.citation: Am J Psychiatry. 1992 May;149(5):664-70
references.pmid: 1575258
references.citation: Neuropsychopharmacology. 2000 Aug;23(2):138-50
references.pmid: 10882840
references.citation: Eur J Neurosci. 2006 May;23(10):2677-85
references.pmid: 16817870
references.citation: Drug Alcohol Depend. 2011 Nov 1;118(2-3):92-9
references.pmid: 21514751
references.citation: Psychopharmacology (Berl). 2006 Jul;187(1):112-20
references.pmid: 16767421
references.citation: J Neurosci. 2010 Dec 1;30(48):16149-59
references.pmid: 21123561
references.citation: Eur J Neurosci. 2012 Dec;36(11):3549-58
references.pmid: 23039920
references.citation: J Neurosci. 2013 Jan 16;33(3):950-60
references.pmid: 23325234
references.citation: Neurosci Biobehav Rev. 2010 Nov;35(2):151-6
references.pmid: 20438754
references.citation: Biol Psychiatry. 2011 Jun 1;69(11):1083-90
references.pmid: 21334600
references.citation: Neuropsychopharmacology. 2009 Jul;34(8):1926-35
references.pmid: 19279570
references.citation: Brain Res Brain Res Rev. 2004 Dec;47(1-3):145-60
references.pmid: 15572169
references.citation: Psychopharmacology (Berl). 2008 Feb;196(3):473-82
references.pmid: 17965976
references.citation: Psychopharmacology (Berl). 2004 Aug;175(1):26-36
references.pmid: 15042275
references.citation: J Neurophysiol. 2009 Jun;101(6):3192-8
references.pmid: 19357347
references.citation: J Neurosci. 2004 Jul 28;24(30):6686-92
references.pmid: 15282271
references.citation: J Neurosci. 2011 Aug 3;31(31):11396-403
references.pmid: 21813699
references.citation: Arch Gen Psychiatry. 1991 Jan;48(1):43-51
references.pmid: 1984761
references.citation: Biol Psychiatry. 2010 Aug 1;68(3):231-9
references.pmid: 20554270
references.citation: J Comp Neurol. 2000 Dec 11;428(2):191-212
references.pmid: 11064361
references.citation: J Neurosci. 1997 Apr 1;17(7):2605-14
references.pmid: 9065520
references.citation: Neuropsychopharmacology. 2008 Mar;33(4):814-26
references.pmid: 17534378
references.citation: J Comp Neurol. 2008 Dec 10;511(5):628-57
references.pmid: 18853414
references.citation: J Pharmacol Exp Ther. 2010 Dec;335(3):743-53
references.pmid: 20858707
references.citation: J Neurosci. 2012 Oct 17;32(42):14804-8
references.pmid: 23077064
references.citation: J Neurosci. 2010 Jan 6;30(1):218-29
references.pmid: 20053904
references.citation: Psychopharmacology (Berl). 2000 Oct;152(2):140-8
references.pmid: 11057517
references.citation: Science. 2004 Mar 26;303(5666):2040-2
references.pmid: 15044807
references.citation: J Neurosci. 1998 Jul 15;18(14):5529-36
references.pmid: 9651233
references.citation: Neuropsychopharmacology. 2006 Oct;31(10):2188-96
references.pmid: 16341025
references.citation: Psychoneuroendocrinology. 2005 Oct;30(9):880-91
references.pmid: 15975729
references.citation: J Comp Neurol. 2006 Jan 1;494(1):142-78
references.pmid: 16304685
references.citation: Psychopharmacology (Berl). 2011 Nov;218(1):29-37
references.pmid: 21336579
references.citation: J Neurosci. 2002 Jul 1;22(13):5713-8
references.pmid: 12097523
references.citation: Addict Behav. 2006 Feb;31(2):351-4
references.pmid: 15951125
references.citation: Neuroscience. 2007 Nov 30;150(1):8-13
references.pmid: 17961928
references.citation: Neuropharmacology. 2009;56 Suppl 1:18-31
references.pmid: 18725236
references.citation: Behav Brain Res. 2006 Nov 1;174(1):1-8
references.pmid: 16920204
references.citation: Neuropsychopharmacology. 2005 Apr;30(4):657-68
references.pmid: 15602500
references.citation: Psychoneuroendocrinology. 1998 Apr;23(3):219-43
references.pmid: 9695128
references.citation: J Neurosci. 2002 Jun 15;22(12):5173-87
references.pmid: 12077212
references.citation: Am J Addict. 1998 Spring;7(2):128-35
references.pmid: 9598216
references.citation: J Psychopharmacol. 2012 Jul;26(7):958-72
references.pmid: 22234929
references.citation: Psychopharmacology (Berl). 2003 Jul;168(1-2):44-56
references.pmid: 12652346
references.citation: Biol Psychiatry. 2009 Jul 15;66(2):110-7
references.pmid: 19217073
references.citation: J Neurosci. 2012 Nov 7;32(45):15779-90
references.pmid: 23136417
references.citation: Endocrinology. 2006 Dec;147(12):5549-56
references.pmid: 16946006
references.citation: Br J Pharmacol. 1970 Nov;40(3):528-30
references.pmid: 5497802
references.citation: Physiol Behav. 2009 Dec 7;98(5):614-7
references.pmid: 19800355
references.citation: J Neurosci. 2013 Jul 17;33(29):11800-10
references.pmid: 23864669
references.citation: J Comp Neurol. 2005 Sep 26;490(3):270-94
references.pmid: 16082674
references.citation: J Neurosci. 2009 May 20;29(20):6535-44
references.pmid: 19458224
references.citation: Brain Struct Funct. 2008 Sep;213(1-2):43-61
references.pmid: 18651175
references.citation: Nat Neurosci. 1998 Sep;1(5):349-51
references.pmid: 10196521
references.citation: Neurosci Lett. 1987 Jun 1;77(1):25-30
references.pmid: 3110702
references.citation: Am J Addict. 2009 Nov-Dec;18(6):481-7
references.pmid: 19874169
references.citation: Eur Neuropsychopharmacol. 2008 Apr;18(4):303-11
references.pmid: 17920248
references.citation: Psychopharmacology (Berl). 1998 May;137(2):184-90
references.pmid: 9630005
references.citation: J Neurosci. 2011 Jun 8;31(23):8476-90
references.pmid: 21653852
references.citation: Eur J Neurosci. 1999 Apr;11(4):1119-26
references.pmid: 10103108
references.citation: Neuron. 2003 Jul 31;39(3):401-7
references.pmid: 12895416
references.citation: J Neurosci. 2004 Feb 18;24(7):1551-60
references.pmid: 14973230
references.citation: Proc Natl Acad Sci U S A. 1984 Mar;81(5):1585-9
references.pmid: 6324206